مقالوصول مغلق2025
Natural Product Research · مجلد 40 (14) · 4264-4271
This novel study investigates the bioactive compounds in the roots of Aporosa cardiosperma (Gaertn.) MerrA. cardiosperma, a tree with significant use in traditional Asian medicine. Through a comprehensive chromatographic approach, including TLC, HPTLC, GC-MS, and LC-MS, this research offers new insights into the plant’s bioactive profile. Sequential extraction with solvents of varying polarity was followed by phytochemical screening and quantification of flavonoids and phenolic compounds. The results revealed a diverse range of bioactive components, including flavonoids, terpenoids, phenols, and steroids, with the highest concentrations found in methanolic and ethanolic extracts. Notably, the ethanolic extract contained 7.0 ± 0.03 mg of phenolics and 30.1 ± 0.04 mg of flavonoids. The GC-MS identified 31 compounds, and LC-MS detected 15, including phyllanthacidoid methyl ester, beta-sitosterol, gallic acid, rutin, ellagic acid, and chlorogenic acid. This groundbreaking research highlights A. cardiosperma’s therapeutic potential and paves the way for its future application in modern medicine.
root phytochemicalsflavonoidsphenolic compoundsterpenoids
مقالوصول مفتوح2025
Cureus · مجلد 17 (5) · e84877-e84877
Synchronous colorectal and small bowel adenocarcinomas are exceptionally rare. This case report presents a 65-year-old male patient with acute bowel obstruction who underwent an emergency laparotomy. Intraoperative findings revealed synchronous sigmoid colon and small bowel tumors with peritoneal metastases. The patient underwent sigmoidectomy, small bowel resection, and metastasectomy. Histopathology confirmed two distinct primary adenocarcinomas. Postoperative management included KRAS mutation-guided chemotherapy. At the two-year follow-up, the patient remained disease-free. This case highlights the importance of thorough intraoperative exploration in emergency presentations and demonstrates the potential for favorable outcomes with aggressive multimodal treatment in synchronous gastrointestinal malignancies.
small bowel adenocarcinomasigmoid colon canceracute intestinal obstructionperitoneal carcinomatosis
نسخة أوليةمفتوح (مستودع)2025
—
A robust, reproducible pipeline to (i) generate realistic synthetic RNA-seq data for visual-impairment research using a Negative Binomial model, (ii) build and train a 1D-CNN classifier, (iii) evaluate performance via ROC-AUC and SHAP interpretability, and (iv) publish both code and datasets to public repositories (Protocols.io & NCBI GEO).
visual impairmentnegative binomial regressionSHAParea under the receiver operating characteristic
سحبوصول مغلق2025
International Immunopharmacology · مجلد 157 · 114781-114781
metformindiabetic retinopathyTLR4nuclear factor-kappaB
مقالوصول مفتوح2025
Dermatology Reports · مجلد 17 (4)
Acute generalized exanthematous pustulosis (AGEP) is a rare pustular eruption commonly triggered by drugs. It is characterized by acute onset of pustules on erythematous-edematous skin and often presents with fever. This report describes AGEP following exposure to iodinated contrast media (ICM), specifically iobitridol, in a 68-year-old male with multiple comorbidities. The patient developed characteristic erythematous patches with pustules on the body after initial CT imaging with ICM for a prostate abscess. Histological findings and recurrence following re-exposure confirmed AGEP, which was attributed to ICM. This case emphasizes the need for awareness of ICM as a potential trigger for AGEP. Management included topical steroids and antihistamines, resulting in a rapid recovery.
acute generalized exanthematous pustulosisiodinated contrast mediaiobitridolcontrast media hypersensitivity
مقالمفتوح (مستودع)2025
Dialnet (Universidad de la Rioja)
Background: Urinary tract infections are a very common type of infection in the urinary system. It's more common in female, Elderly, recent catheterization and Sexual Activity. The disease can involve any part of your urinary system from a relatively benign cystitis to potentially life-threatening pyelonephritis. They are the most common infection among elderly population and the most common cause of hospitalization. The diagnosis and treatment of urinary tract infections in elderly people is considered difficult due to certain risk factors include diabetes mellitus, aging, impaired immunity, spinal cord injuries and the use of urinary catheters. Methods: A retrospective observational study was conducted between January 2020 and December 2024. A total of 350 elderly patients (≥65 years) diagnosed with urinary tract infections were included. Data were extracted from electronic medical records, including sociodemographic characteristics, comorbidities, medication regimens, and treatment outcomes. Descriptive statistics were used to summarize data, and logistic regression was performed to identify predictors of poor treatment outcomes. Results: Among the study population, 63.5% had complicated urinary tract infections, with hypertension (62.4%) and diabetes mellitus (48.2%) being the most common comorbidities. Polypharmacy (≥5 medications) was present in 63.5% of patients, and 14.1% were on ≥10 medications. Nitrofurantoin (32.9%) and ciprofloxacin (25.9%) were the most commonly prescribed antibiotics. Older age (≥85 years, OR=2.5, p<0.001) diabetes mellitus (OR=1.9, p<0.001), chronic kidney disease (OR=2.2, p<0.001), urinary catheterization history (OR=2.8, p<0.001), and polypharmacy (OR=1.7, p=0.002) were significant predictors of poor treatment outcomes. Conclusion: Elderly patients with urinary tract infections frequently present with multiple comorbidities and high medication burdens, complicating treatment and increasing the risk of adverse outcomes. Polypharmacy and chronic conditions such as diabetes and chronic kidney disease significantly impact treatment success. Improved antibiotic stewardship and individualized treatment strategies are needed to optimize outcomes in this vulnerable population.
urinary tract infectionelderly patientstreatment outcomespolypharmacy
مقالوصول مفتوح2025
Saudi Journal for Health Sciences · مجلد 14 (2) · 139-149
ABSTRACT Familial hypercholesterolemia (FH) is a genetic disorder characterized by high levels of low-density lipoprotein cholesterol (LDL-C). If left untreated during childhood, FH can result in early-onset cardiovascular disease (CVD). Statin treatment can reduce the risk of early-onset atherosclerotic CVD associated with FH. For this atherosclerosis-related condition, early therapy is essential to avoid major cardiac damage. The systematic review was performed following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines, with a comprehensive electronic search carried out across the Web of Science, EBSCO, and PubMed databases. The search terms used included combinations of keywords and medical subject headings relevant to the study objective. The search string was: statins OR familial hypercholesterolemia OR children OR adolescents OR LDL cholesterol OR cholesterol-lowering therapy OR pediatric hypercholesterolemia OR statin efficacy OR statin safety OR long-term outcomes OR cardiovascular risk OR lipid management OR growth and development. This study included 18 articles with a total sample size of 2811 participants. The findings revealed that in the group treated with statins, total cholesterol (TC), LDL-C, and triglycerides decreased by MD = −31.16 (95% confidence interval [CI]: −42.12, −20.19), MD = −14.31 (95% CI: −20.91, −7.70), and MD = −5.53 (95% CI: −6.35, −4.72), respectively. Although there was an increase in high-density lipoprotein cholesterol (HDL-C) by MD = 0.29 (95% CI: −0.45, 1.03), but the difference was not statistically significant ( P = 0.45). Statins significantly reduce TC, LDL-C, and TG in children and adolescents with FH while increasing HDL-C levels. On the other hand, this study found statin to be efficient in treating children and adolescents with familial hypercholesterolemia. Similarly, the study did not find any safety issues with statin medication. However, this study suggests future studies focusing on randomized control trials only, in order to ascertain the results obtained in this study.
statinsfamilial hypercholesterolemiapediatric hypercholesterolemiachildren and adolescents
فصل كتابوصول مغلق2025
Advances in computational intelligence and robotics book series · 275-302
Medication adherence remains a significant challenge within healthcare systems globally, especially among groups with chronic illnesses like diabetes, hypertension, and asthma. Despite universally accessible, low-cost Artificial Intelligence (AI) technologies to adherence, an information crevice exists on the utilization of this innovation and its effect on medicine self-efficacy and pharmaceutical adherence in therapeutically underserved populations with an assortment of persistent sicknesses. AI-enabled smartphone applications have surfaced as an encouraging remedy, presenting innovative methods to monitor patient behaviors, verify medication consumption, and deliver personalized reminders. By utilizing real-time monitoring, tailored communication, and behavioral nudges, AI can tackle the various barriers to medication adherence through creative solutions, including forgetfulness, lack of motivation, and insufficient health literacy, while fostering improved health outcomes, particularly among individuals with chronic conditions.
medication adherenceartificial intelligencemobile applicationchronic disease
فصل كتابوصول مغلق2025
Advances in computational intelligence and robotics book series · 169-188
This chapter discusses the roles of digital biomarkers and artificial intelligence in enhancing precision therapeutics, which is the adaptation of treatments to a person's biomarker patterns for improving an individual's health. Digital biomarkers are collected from wearable technology and other digital devices that record variations in physiological and behavioral indexes thus improving disease diagnosis and treatment. This AI augments these biomarkers' prognostic accuracy and unearths patterns within large datasets within clinical settings; a major change to individualized care. This chapter in the book describes passive and active data acquisition in actual clinical scenarios and offers a conceptual foundation for employing digital biomarkers and artificial intelligence in trials. It also examines diagnostic image analysis and more specifically, the use of MRI to monitor Parkinson's disease, and EEG in managing mental health.
digital biomarkersartificial intelligenceprecision therapywearable devices
فصل كتابوصول مغلق2025
Advances in computational intelligence and robotics book series · 363-376
This chapter provides an overview of the history and impact of artificial intelligence on businesses, with a specific focus on the pharmaceutical industry and research. It discusses the basic principles of pharmacoeconomics, explores ways AI can enhance business processes, and examines various applications of AI in pharmaceutical research, such as drug development, digital therapy, personalized treatment, clinical trials, epidemic forecasting, and supply chain management. The chapter also addresses challenges and considerations related to ethics, safety, data privacy, and liability in AI implementation. Finally, the discussion provides insights into AI's economic opportunities and implications in pharmaceutical research.
artificial intelligencepharmaceutical industrypharmacoeconomicsdrug development
مقالوصول مفتوح2025
Universa Medicina · مجلد 44 (1) · 113-128
It is of the utmost importance to diagnose and treat tension pneumothorax (TPX) as soon as possible, because if not recognized and treated, it may swiftly cause collapse of the respiratory and circulatory systems. An estimated 5% of people with serious thoracic injuries may die from this avoidable cause, making it a leading cause of death in trauma and prehospital situations. Methods for diagnosis, procedures for intervention, and strategies for training are the primary foci of this study, which aims to provide a synthesis of evidence-based protocols for the prehospital treatment of TPX. A literature search was done on Pubmed and Google Scholars databases to identify the relevant literature from 2015 to 2025. This review focuses on the use of point-of-care ultrasonography to improve diagnosis accuracy and assesses the effectiveness of needle decompression and finger thoracostomy as first-line therapies. We will go over the main research that back these methods, how they differ between regions, and the difficulties of implementing them in prehospital care. Standardized training methods and further studies on appropriate intervention strategies are two of the significant gaps in the literature that are pointed out in this review. These results provide suggestions for improving prehospital care, increasing survival rates, and enhancing clinical practice. This review highlights current evidence-based strategies for diagnosing and managing tension pneumothorax (TPX) in prehospital settings. It emphasizes advancements such as point-of-care ultrasound (POCUS) and interventions such as needle decompression and finger thoracostomy. The review also addresses challenges in protocol implementation, especially in developing EMS systems such as in Saudi Arabia, citing issues such as training disparities, limited resources, and system readiness.
tension pneumothoraxprehospital careemergency medical servicespoint-of-care ultrasound
مقالوصول مفتوح2025
Cureus · مجلد 17 (4) · e82819-e82819
Objective Postpartum depression (PPD) is a common yet often underdiagnosed mental health condition that can significantly affect maternal well-being and neonatal outcomes. Despite growing awareness, PPD remains insufficiently studied within specific cultural contexts, such as Saudi Arabia, where social and familial expectations may influence maternal mental health. This study aimed to assess the prevalence of PPD in Saudi women and investigate its association with neonatal health outcomes and maternal risk factors. Methods A retrospective cross-sectional study was conducted at the Psychiatry Department of King Fahad Medical City, Riyadh, Saudi Arabia, between 2019 and 2022. Medical records of 200 postpartum women were screened, and 56 eligible patients diagnosed with PPD were included. Diagnosis of PPD was based on clinical evaluation supported by the Edinburgh Postnatal Depression Scale (EPDS), a validated screening tool routinely used in the department. Data were collected using a structured review form covering demographic, clinical, and neonatal variables. Descriptive analysis was performed using the Statistical Package for the Social Sciences (SPSS). Odds ratios (OR) and 95% confidence intervals (CI) were calculated to assess the strength of association between PPD and potential risk factors. Results In this study, 56 Saudi Muslim women were investigated with a mean age of 35 years. The majority were married, 54 (92.9%). Regarding consanguinity, 25 (44.6%) had consanguineous marriages, 39 (69.6%) had planned pregnancies, and 28 (50%) females were suffering from different health conditions. Regarding symptom onset, 33 (58.9%) started to feel it after birth, and 23 (41.1%) had maternal complications. Most mothers were diagnosed with PPD after the birth of male infants, and 33 (58.9%) of the mothers were diagnosed with depression with their first newborn baby. Furthermore, 39 children (69.6%) suffered from chronic disease. Conclusion This study underscores the complex interplay of clinical, psychosocial, and obstetric factors in the development of PPD among Saudi mothers. Significant associations were identified with primiparity, vaginal delivery, life stressors, and pregnancy-related difficulties, emphasizing the need for early recognition and targeted support. Conversely, factors such as infant gender, consanguinity, and neonatal health issues were not significant predictors. These findings highlight the importance of culturally sensitive postpartum screening strategies and reinforce the value of integrated mental health services within maternal care frameworks to promote early intervention and optimize outcomes for both mother and child.
postpartum depressionprevalencerisk factorsneonatal outcomes
تصحيحوصول مفتوح2025
Biomedicine & Pharmacotherapy · مجلد 187 · 118042-118042
mesenchymal stem cell-derived exosomesAlzheimer's diseaseautophagyinsulin signaling
مقالمفتوح (مستودع)2025
Journal of Advanced Trends in Medical Research · مجلد 2 (2) · 326-335
Abstract Background: Sleep disturbances are highly prevalent in rheumatoid arthritis (RA) patients, significantly impacting quality of life and disease outcomes. However, the complex relationships between sleep quality, pain, inflammation and psychological factors remain poorly quantified. Methods: This cross-sectional study included 325 RA patients from multiple rheumatology centres across Saudi Arabia and the Middle East. Sleep quality was assessed using the Pittsburgh Sleep Quality Index and Insomnia Severity Index. Pain was evaluated using multiple measures to distinguish between inflammatory pain (Visual Analogue Scale pain and Brief Pain Inventory) and non-inflammatory pain (pain DETECT and Pain Catastrophizing Scale). Inflammation was assessed through disease activity measures and inflammatory markers. Psychological factors were measured using validated scales for depression, anxiety and stress. Structural equation modelling was used to test direct and indirect relationships between these factors and sleep quality. Results: The final structural equation model explained 72% of the variance in sleep quality. Non-inflammatory pain ( β = 0.31, P < 0.001) and psychological factors ( β = 0.48, P < 0.001) had significant direct effects on sleep quality, whereas inflammation and inflammatory pain influenced sleep quality primarily through indirect pathways. The total effects were largest for psychological factors ( β = 0.48) and non-inflammatory pain ( β = 0.50), followed by inflammation ( β = 0.33) and inflammatory pain ( β = 0.23). Multi-group analyses revealed stronger effects of non-inflammatory pain on sleep quality in females and older patients, while psychological factors had stronger effects in younger patients. Conclusion: Sleep quality in RA is determined by a complex interplay of pain mechanisms, inflammation and psychological factors. Non-inflammatory pain and psychological factors have the strongest direct effects on sleep quality, while inflammation and inflammatory pain exert their influence primarily through indirect pathways. These findings suggest that addressing central pain mechanisms and psychological comorbidities may be particularly important for improving sleep in RA patients.
rheumatoid arthritissleep qualitysleep disordersnon-inflammatory pain
مقالمفتوح (مستودع)2025
Journal of Advanced Trends in Medical Research · مجلد 2 (2) · 270-278
Abstract Background: Hypertrophic cardiomyopathy (HCM) is when the heart muscle becomes thickened, which affects the function of the heart. It affects approximately 1 in 500 individuals in the general population. It is a multifactorial nature but is mainly caused by abnormal genes in the heart muscles. Many patients with HCM are non-symptomatic, and it is diagnosed typically with echocardiogram. HCM is marked by left ventricular hypertrophy, myocardial fibrosis and elevated risk of sudden cardiac death. The goal is to create a comprehensive analytical framework that clarifies the intricate relationships that exist between molecular pathways, environmental influences, genetic variations and clinical outcomes in HCM. Methods: We analysed 50 HCM patients using network analysis and structural equation modelling. We modelled HCM as a complex biological system using multilayered network analysis. Clinical symptoms, environmental triggers, molecular and cellular processes and genetic predisposition are interconnected in this framework. These layers were linked to uncover disease-supporting hubs, bottlenecks and subnetworks. Integrative approaches provide systems-level knowledge of HCM pathophysiology beyond reductionist, single-factor models. Results: The SEM revealed significant gene-environment interactions, with sarcomere mutations driving disease through sarcomere dysfunction and energy depletion, while environmental factors (exercise, diet) modulated progression through hypertrophic signalling. The model improved risk stratification accuracy (82% vs. 65% in traditional models) and identified three phenotypic subtypes. Conclusion: The multifaceted character of HCM, where environmental factors and genetic abnormalities interact to define disease progression, is highlighted by this study. By including these elements, risk assessment is improved and tailored care is informed.
hypertrophic cardiomyopathydisease progressiongene-environment interactionsarcomere gene mutations